A phase I/II trial of BMS-247550 for patients with recurrent high-grade gliomas.

被引：0
|
作者：
Peereboom, D
Carson, K
Lawson, D
Lesser, G
Supko, J
Grossman, S
机构：
[1] Cleveland Clin, Brain Tumor Inst, Cleveland, OH 44106 USA
[2] Johns Hopkins Oncol Ctr, Baltimore, MD USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Wake Forest Univ, Winston Salem, NC 27109 USA
[5] MGH Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1546
引用
收藏
页码：118S / 118S
页数：1
相关论文
共 50 条
  • [1] NABTT 2111: A phase I trial of BMS-247550 for patients with recurrent high-grade gliomas.
    Peerebom, D
    Batchelor, T
    Lesser, G
    Phuphanich, S
    Mikkelsen, T
    Carson, K
    Desideri, S
    Fisher, J
    Grossman, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 129S - 129S
  • [2] A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas.
    Clarke, Jennifer Leigh
    Molinaro, Annette M.
    DeSilva, Ashley A.
    Rabbitt, Jane E.
    Drummond, Daryl C.
    Chang, Susan Marina
    Butowski, Nicholas A.
    Prados, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
    Kreisl, Teri N.
    Kotliarova, Svetlana
    Butman, John A.
    Albert, Paul S.
    Kim, Lyndon
    Musib, Luna
    Thornton, Donald
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2010, 12 (02) : 181 - 189
  • [4] A phase II trial of LY317615 in patients with recurrent high grade gliomas.
    Fine, HA
    Kim, L
    Royce, C
    Mitchell, S
    Duic, JP
    Albert, P
    Musib, L
    Thornton, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [5] Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas
    Fine, HA
    Wen, PY
    Maher, EA
    Viscosi, E
    Batchelor, T
    Lakhani, N
    Figg, WD
    Purow, BW
    Borkowf, CB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2299 - 2304
  • [6] Phase I trial of BMS-247550 and gemcitabine in patients with advanced solid tumor malignancies.
    Anderson, S
    Dizon, D
    Sabbatini, P
    Dupont, J
    Pezzulli, S
    Massey, A
    Aghajanian, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 151S - 151S
  • [7] A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma
    Ott, Patrick A.
    Hamilton, Anne
    Jones, Amanda
    Haas, Naomi
    Shore, Tsiporah
    Liddell, Sandra
    Christos, Paul J.
    Doyle, L. Austin
    Millward, Michael
    Muggia, Franco M.
    Pavlick, Anna C.
    [J]. PLOS ONE, 2010, 5 (01):
  • [8] A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas
    David M. Peereboom
    Jeffrey G. Supko
    Kathryn A. Carson
    Tracy Batchelor
    Surasak Phuphanich
    Glenn Lesser
    Tom Mikkelson
    Joy Fisher
    Serena Desideri
    Xiaoying He
    Stuart A. Grossman
    [J]. Journal of Neuro-Oncology, 2010, 100 : 261 - 268
  • [9] A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas
    Peereboom, David M.
    Supko, Jeffrey G.
    Carson, Kathryn A.
    Batchelor, Tracy
    Phuphanich, Surasak
    Lesser, Glenn
    Mikkelson, Tom
    Fisher, Joy
    Desideri, Serena
    He, Xiaoying
    Grossman, Stuart A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (02) : 261 - 268
  • [10] Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
    Manmeet S. Ahluwalia
    Carol Patton
    Glen Stevens
    Tanya Tekautz
    Lilyana Angelov
    Michael A. Vogelbaum
    Robert J. Weil
    Sam Chao
    Paul Elson
    John H. Suh
    Gene H. Barnett
    David M. Peereboom
    [J]. Journal of Neuro-Oncology, 2011, 102 : 317 - 321
12345